Title: 2016 ACVIM Forum Research Abstract Program Document date: 2016_5_31
ID: 2y1y8jpx_189
Snippet: This study adds to the evidence that metronomic cyclophosphamide may have some use in the treatment of malignant mesenchymal and epithelial tumours. However, it is important to note that even at low doses side effects may occur. The purpose of this study was to solicit and compile data from practicing veterinary specialists regarding their use of toceranib in cats with mast cell neoplasia and to provide initial assessment of possible clinical ben.....
Document: This study adds to the evidence that metronomic cyclophosphamide may have some use in the treatment of malignant mesenchymal and epithelial tumours. However, it is important to note that even at low doses side effects may occur. The purpose of this study was to solicit and compile data from practicing veterinary specialists regarding their use of toceranib in cats with mast cell neoplasia and to provide initial assessment of possible clinical benefit and toxicity.
Search related documents:
Co phrase search for related documents- clinical benefit and low dose: 1, 2, 3, 4, 5, 6, 7, 8
- clinical benefit and possible clinical benefit: 1, 2, 3, 4, 5, 6
- clinical benefit and study purpose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- initial assessment and low dose: 1, 2, 3
- initial assessment and study purpose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- low dose and metronomic cyclophosphamide: 1
- low dose and study purpose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- low dose effect and study purpose: 1, 2
Co phrase search for related documents, hyperlinks ordered by date